trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


VISMED® GEL MULTIHigh protection, anytime, anywhere

pack_vismed_gel_multi_rgb_72dpi_kombi.jpg

 

VISMED® GEL MULTI has the same hypotonic and non-preserved formulation as VISMED® GEL with 0.3% hyaluronic acid and essential ions but presented in the preservative-free multidose dispenser.

This special delivery system allows VISMED® GEL MULTI to remain sterile and free from contamination for up to 3 months after opening. Its ergonomic and intuitive delivery system, 10 ml content and compact size design make it the perfect solution for a long lasting relief of more severe dry eye conditions.

Always at hand…high protection, anytime, anywhere.


diacerein_logo.gif

Oral inhibition of interleukin-1 in the treatment of osteoarthritis.

DIACEREIN is indicated for the specific, long-term oral treatment of degenerative joint diseases (osteoarthritis and related diseases). DIACEREIN has a unique mode of action through inhibition of the production and activity of interleukin-1, the key mediator in the progression of osteoarthritis.

DIACEREIN is effective in reducing pain and functional impairment, the major symptoms of OA, and has shown structure-modifying effects with good gastrointestinal tolerability.

 

diacerein_box01.jpg

Diacerein is sold under the tradenames ARTRODAR®, ARTRODARIN®, ARTROLYT®, ARTRIZONA®, GALAXDAR®, GLIZOLAN®, VERBORIL®.

  
trb_lock.gif Doctor information
Distributors
trb_contact.gifContacts

News-Events
 
 
  • English